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ABSTRACT - PURPOSE: Ischemia-reperfusion injury is a common complication in liver surgery with oxidative 
stress related graft failure as a potential complication. The oxidative stress could affect hepatic drug transporters 
such as P-glycoprotein, which is crucial in the hepatic clearance of certain immunosuppressant drugs. Thus,, it is 
important to study its function after ischemia-reperfusion injury in vivo. Rhodamine 123 is a fluorescent substrate 
of P-glycoprotein and its hepatic disposition can be visualized using multiphoton microscopy in vivo using 
anaesthetized animals. The aim of this study was to investigate the effect of long-term ischemia-reperfusion injury 
on P-glycoprotein function in hepatocytes using in vivo multiphoton microscopy. METHODS: Localized ischemia 
was induced for 1 hour in rats. The liver was reperfused for 4, 24, 48 hours or 1 week, where-after rhodamine 123 
was injected intravenously. Multiphoton microscopy imaged the liver and bile was collected continuously up to 6 
hours following drug administration. The liver was harvested for histology andprotein expression of P-
glycoprotein. RESULTS: Ischemia-reperfusion injury resulted in extensive liver damage, inflammatory cell 
infiltration and apoptosis in the midzonal and centrilobular regions of the liver acinus. P-glycoprotein protein 
expression decreased. Cellular concentration of rhodamine 123 increased as visualized by multiphoton 
microscopy, which was confirmed with decreased excretion of rhodamine 123 in collected bile. CONCLUSIONS: 
This study showed reduced function of P-glycoprotein in ischemia-reperfusion injury as reflected by decreased 
biliary excretion of Rhodamine 123, as well as reduced protein expression of the transporter. Multiphoton 
microscopy could be used to visualize and quantitate the intracellular levels of rhodamine 123. These findings 
stipulate the importance of using multiphoton microscopy to understand transmembrane drug flux and reflect on 
careful drug dosing after hepatic surgery. 
 
This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For 
Readers”) may comment by clicking on ABSTRACT on the issue’s contents page. 
_______________________________________________________________________ 
 
INTRODUCTION 
 
Ischemia-reperfusion (I/R) injury is a common 
occurrence in liver surgery (e.g. liver transplantation 
and hepatic resection) where it is a major cause of 
morbidity and mortality (1, 2). In liver 
transplantation, the damage caused by ischemia is 
intensified when the transplanted liver is reperfused 
with blood (3). Reperfusion allows reintroduction of 
oxygenated blood resulting in oxidative stress, which 
causes increased microvascular permeability, 
intracellular ATP loss, inflammatory cell infiltration 
and potentially cell death (4-6). Oxidative stress 
could also lead to graft failure and rejection of the 
transplanted liver (7). The liver acinus is divided into 
three zones, where zone 1 is localized around the 
portal tract, zone 3 around the hepatic venules and 
zone 2 is in the midsection in between zone 1 and 
zone 3. Cells in zone 1 are exposed to high 
concentrations of oxygen and nutrients, whereas the 
blood reaching zone 3 has a lower concentration of 
these substrates (8). Investigations of I/R injury in 
different zones in the liver are limited. Our group has 
shown predominant damage in zone 2 and 3 in early 
ischemia reperfusion injury (9). Cellular changes in 
I/R injury have been shown to affect membrane 
proteins (10-12), which could lead to changes in drug 
distribution. In this study we explore the long-term 
effect of I/R injury on the liver acinus. 
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Rhodamine 123 (Rh123) is a cationic fluorescent 
dye and substrate of P-glycoprotein (Pgp) (13), an 
ATP-dependent efflux transporter (14) widely 
expressed in the bile canalicular membrane of 
hepatocytes, intestinal epithelium, renal proximal 
tubules (15) and capillary endothelial cells of the 
brain (16). Since Pgp plays a critical role on hepatic 
disposition of immunosuppressant drugs such as 
cyclosporine A and tacrolimus (17), it is of 
importance to understand its function in I/R injury. 
Limited studies have investigated protein 
expression of transporters on I/R injury (11, 12, 18, 
19), however, only one recent paper has investigated 
the function of Pgp by examining the biliary 
excretion pattern of Rh123 in the isolated perfused 
rat liver (20). Our study adds to these reports by 
utilizing multiphoton microscopy (MPM) to 
visualize the change in intracellular drug 
concentration of Rh123 in space and time in vivo 
following I/R injury. 
Multiphoton microscopy (MPM) enables high 
resolution imaging of physiology, morphology as 
well as cell-cell interactions in live animals and 
intact tissues through fluorescence intensity imaging 
(21). In order to excite an electron from a fluorescent 
molecule, two or more low energy photons are 
absorbed simultaneously (22, 23). The photons 
absorbed have similar energies and produce 
excitation equivalent to single photon absorption 
possessing twice the energy (21). MPM allows for 
non-invasive imaging of fluorescent molecules in 
biological tissues and has been widely used in 
neuroscience (24), cancer research (25), 
immunology (26) and ophthalmology (27). 
However, data showing the usefulness of MPM in 
studying hepatic drug distribution is limited, 
particularly in the injured liver. We previously used 
MPM to follow the metabolism of fluorescein (28, 
29) and disposition of rhodamine 123 (Rh123) in 
normal rat liver in vivo (30). The aim of the present 
study was to investigate the function of Pgp using in 
vivo MPM in anaesthetized rats in combination with 
bile excretion data and plasma concentration as well 
as protein expression of Rh123 in the liver. 
 
METHODS 
 
Chemicals and Reagents 
Rhodamine 123 was purchased from Sigma Aldrich 
(St Louis, MO). Ketamin hydrochloride (anesthesia) 
and Ilium Xylazil-20 (analgesic, sedative and muscle 
relaxant) were obtained from Parnell laboratories, 
Australia, and Bayer Australia (Pymble NSW, 
Australia), respectively. Reagents used for Western 
blot analysis were purchased from Thermo Fisher 
(Supersensitive West Femto Maximum Sensitivity, 
Pierce BCA Protein Assay Kit, Dental Developer 
replenisher, Dental fixer replenisher and T-mat g 
film); Whatman (Whatman filter paper) and Bio-rad 
(Protein std precision plus BIO-Rad, IMMuno-blot 
membrane PVDF, 10 x TGS Buffer, 10 x TG Buffer, 
30% Acrylamide/Bis Solution, 29:1, TEMED and 
Ammonium Persulfate). P-glycoprotein monoclonal 
antibody (JSB-1; Catalogue number AB3366) was 
purchased from Sapphire Bioscience (Sydney NSW, 
Australia). The secondary antibody, Peroxidase 
AffiniPure Goat Anti-Mouse IgG (H+L) (min X 
Hu,Bov,Hrs, Rb,Sw Sr Prot), was purchased from 
Jackson ImmunoResearch Laboratories, Inc, (West 
Grove, PA, USA).  
 
Animals 
Male Wistar rats, weighting 300 ±30 grams, 
purchased from the Animal Resource Centre (Perth, 
WA, Australia), were used in all experiments. 
Principles of laboratory animal care (NIH 
publication no. 85–23, revised 1985) were followed. 
In addition, all studies were approved by the Animal 
Ethics Committee of the University of Queensland. 
Rats were housed in the Biological Resource Facility 
at the Princess Alexandra Hospital, where the 
temperature was maintained at 20±1°C and humidity 
at 60-75%, with artificial light for 12 h (7 am to 7 
pm) daily. All animals had unlimited access to food 
and water. 
 
Surgical procedures and I/R model 
Rats were anesthetized initially by an intraperitoneal 
injection of xylazil (10 mg/kg) and ketamine 
hydrochloride (80 mg/kg). Body temperature was 
controlled by placing rats on a heating pad set to 
37°C. A small midline laparotomy, using sterile 
surgery equipment, was performed to expose the 
liver. Sterile cotton tips were used to separate the 
lobes and to localize the portal vein, hepatic, artery 
and bile duct, supplying the median and left lobes of 
the liver. These vessels were then clamped using a 
microvascular clamp, causing approximately 70% 
ischemia. The rat was closely monitored and 
anesthesia was maintained throughout the 
experiment by administering maintenance doses of 
ketamine (2.2 mg/100g) and xylazil (0.25 mg/100g). 
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The clamp was removed after 60 min to allow 
reperfusion of the liver for 4, 24, 48 h or 1 week. The 
wound was sutured, muscle and skin separately, 
using sterile silk suture. During the reperfusion rats 
were allowed to recover with close monitoring. Rats 
were given 0.02-0.05 mg/kg of Temgesic® (Pro vet 
PTY LTD, Reckitt Benckiser, NSW, Australia) 
immediately before awakening for pain relief. Sham 
operated rats (controls) underwent the same 
procedure without clamping the vessels and the 
reperfusion phase was set to 24 hours to minimize 
the number of rats in the study, but to account for any 
possible damage resulting from the surgery. At 
specific times of reperfusion rats were again 
anaesthetized. The jugular vein was cleared of 
surrounding tissue and cannulated using PE-tubing 
for administration of Rh123. A midline laparotomy 
was performed, the bile duct exposed and cleared of 
surrounding fat tissue and cannulated using PE10-
tubing for collection of bile. The left lobe of the liver 
was exposed for multiphoton imaging of Rh123 
distribution. The liver and intraperitoneal cavity 
were kept moist by administering 0.9% saline 
continuously throughout the experiment. Rh123, 
dissolved in water (4 mg/kg), was injected 
intravenously at the time of reperfusion, i.e. 4, 24, 48 
h or 1 week after induction of ischemia. Bile was 
collected in pre-weighted tubes every 10 min for 1 
hour and every hour after that for 6 hours. MPM 
images were taken continuously throughout the 
experiment.  
 
Mulitphoton Microscopy (MPM) 
MPM images were taken using a DermaInspect 
system (JenLab GmbH, Jena, Germany) equipped 
with an ultrashort (85 femtosecond pulse width) 
pulsed mode-locked 80-MHz Titanium:Sapphire 
MaiTai laser (Spectra Physics, 25 Mountain View, 
USA). The excitation wavelength was set to 740 nm 
for liver autofluorescence and 900 nm for Rh123 
fluorescence, with an emission range of 350-650 nm. 
The laser power was set to 15mW and the acquisition 
time for obtaining the images was 13.4 s per frame. 
The left lobe of the liver was placed on a small metal 
plate, attached to an adjustable stand that could be 
elevated or lowered as required. The plate was 
slightly raised above the intraperitoneal cavity to 
minimize pressure on the organs underneath and to 
reduce movement in the image from respiration.   
 
 
Image processing 
Images were processed in ImageJ 1.44p (National 
Institutes of Health, USA). Hepatocytes 
(approximately 10) were randomly selected and the 
fluorescence intensity was calculated. A standard 
curve was prepared in livers from control rats, 
without any treatment. The liver was homogenized 
in phosphate buffered saline (pH 7.4) 1:10. Rh123 
was added to the liver homogenate at 0.25, 0.50, 1.0, 
2.0 4.0 and7.8 µg/ml and fluorescence intensity was 
measured using MPM and ImageJ. The intensity 
from hepatocytes was converted into concentrations 
using the standard curve prepared in homogenized 
liver. 
 
Tissue collection 
Blood (0.2 mL) was collected in lithium heparin 
tubes at the time of reperfusion from the inferior vena 
cava using a 30 gauge needle. At the end of the 
experiment, the left and median lobes were excised, 
portions were either snap frozen in liquid nitrogen 
and stored at -70°C for later analysis with Western 
Blot or immersed into 10% buffered formalin for 
histological assessment. 
 
Serum biochemical measurements 
Plasma concentration of alanine aminotransferase 
(ALT) was measured using a Hitachi 747 analyzer 
(Hitachi Ltd., Tokyo, Japan). 
 
High-Performance Liquid Chromatography 
(HPLC) 
The concentration of Rh123 in each collected bile 
sample was determined by HPLC analysis using a 
Luna C18 column (4.6x150 mm, 5 µm) with 
fluorescence detector. Excitation and emission 
wavelengths were 470 and 580 nm, respectively. The 
mobile phase consisted of 20 mM KH2PO4 buffer 
and acetonitrile (3:2, v/v) and was delivered at 1 
mL/min. A standard solution of Rh123 was prepared 
in water and the calibration curve was linear within 
the range of 0.15-5 µg/ml. Each bile sample was 
diluted (1:10) with 0.2 mM acetate buffer and 
incubated for 1 hour. Samples were then further 
diluted in water (1:11). An aliquot of the solution (10 
µL) was injected into the HPLC system (Shimadzu, 
Kyoto, Japan).  
 
Histopathological analysis 
Fixed liver was sub-sectioned onto each slide (2-3 
sections at 5µm from different parts of each liver), 
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stained, and scanned using an Aperio ScanScope XT 
slide scanning system (Aperio Technologies Inc., 
Vista, California, USA) at x20 magnification. Aperio 
ImageScope V10.2 software was used to visualize 
and score the slides. Staining of ApopTag (for 
apoptosis) and immunohistochemistry for ED1 (for 
macrophages/monocytes) was performed according 
to standard procedure. Visualization of ApopTag and 
ED1 localization was simplified with 
diaminobenzidine hydrochloride, which stained 
brown in positively-labeled cells. The number of 
monocytes and macrophages were identified by 
counting ED1-positive cells in the sinusoids in ten 
random fields per slide. Numbers of apoptotic cells 
were identified enzymatically using ApopTag 
labeling, and positive nuclei were counted in ten 
random fields per region per liver slide per zone of 
the liver. Zones identified were periportal, 
centrilobular, and midzonal.   
 
Western Blot 
Liver slices were homogenized (1:20; 
weight:volume) in protein lysis buffer solution, 
triton added (10 μL/ml buffer) and samples stored on 
ice. The solution was centrifuged at 13,000 rpm at 
4oC for 20 min and the supernatant collected. The 
supernatant, equivalent to 50 µg of protein, was 
mixed with loading buffer and heated for 5 min at 
100oC. A 7.5% acrylamide resolving gel and 4% 
stacking gel, both with SDS, were prepared with 
Tris-glycine as running buffer. Samples were 
electrophoresed at 150V for 45 min and blotted onto 
polyvinyl fluoride membrane at 100V for 1 hour at 
4oC. The membrane was blocked in 10% skim milk 
in blocking buffer (tris-buffered saline with 0.1% 
Tween 20 = TBS-T) overnight at 4oC with shaking. 
The membrane was incubated with Pgp antibody, 
1:100 dilution in blocking buffer for 1.5 h and then 
washed with TBS-T. Following incubation with the 
secondary antibody at 1:5000 dilution for 1.5 h, the 
membrane was washed in TBS-T first and then TBS. 
The membrane was developed onto film using 
luminescence kit (SuperSignal® West Femto) 
reacting for 5 min. β-actin was used as a 
housekeeping gene with primary antibody dilution at 
1:1000, and secondary antibody dilution at 
1:200,000. Protein bands were quantified using 
ImageJ and Pgp image results adjusted for the 
loading density bands of β-actin.    
 
STATISTICAL ANALYSIS 
 
An unpaired, parametric t-test with Welch’s 
correction was used. Results were considered 
significant with a p-value ≤ 0.05.  
 
RESULTS 
 
Alanine aminotransferase (ALT) levels 
ALT significantly increased at 4 h (1350 ± 262 U/L) 
and 24 h (736 ± 202 U/L) compared to sham (44.3 ± 
3.79 U/L) (p≤0.05). Values returned to normal levels 
after at 48 h (97.7 ± 20.5 U/L) and 1 week (51.3 ± 
9.20 U/L) of reperfusion (Table 1). The early 
increased ALT level indicated extensive liver 
damage caused by I/R injury. 
 
Histopathology 
Inflammatory cell infiltration (monocytes and 
macrophages) was statistically higher after 24 h (285 
± 26.2) of reperfusion compared to sham (172 ± 
14.2) (n=4, p<0.05). Following 1 week of 
reperfusion, the number of inflammatory cells was 
similar to sham (151 ± 38.9) (Table 1).  
 
 
Table 1. Alanine transaminase (ALT) levels in plasma and inflammatory cells (monocytes/macrophages) in the liver 
after I/R injury at different reperfusion time points. ALT was significantly increased at 4 and 24 h, whereas 
inflammatory cells were significantly increased at 24 h of reperfusion (values ± SEM, *p<0.05, n=4).   
Group ALT (U/L) Number of inflammatory cells 
Sham 44.3±3.79 172±14.2 
4 h 1350±262* 288±69.5 
24 h 736±202* 285±26.2* 
48 h 97.7±20.5 391±84.7 
1 week 51.3±9.20 151±38.9 
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Apoptotic cells were stained by ApopTag and 
counted in each of three different zones of the liver 
acinus (periportal, centrilobular and midzonal) that 
were randomly selected (Figure 1, Table 2). Black 
arrows indicate DNA damaged cells. The number of 
positively stained cells was significantly higher in 
the centrilobular region at 4 h (43.2 ± 12.8) of 
reperfusion compared to sham (6.00 ± 1.47) and in 
the midzonal region at 4 (112 ± 18.2) and 24 h (56.8 
± 5.74) and decreased in the midzonal region after 1 
week of reperfusion (6.25 ± 2.39) (p≤0.05) compared 
to sham (14.0 ± 1.08). No significant difference of 
apoptotic cell numbers was found in the periportal 
region.  
 
  
Figure 1. Apoptotic cells. Positively stained apoptotic cells, in the three regions of the liver acinus, periportal, centrilobular 
and midzonal, were counted in 10 random fields per slide. Black arrows indicate Apoptag-positive cells. 
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I/R induced changes to Pgp transporter 
expression 
Pgp level was measured by Western blot (Figure 2). 
Protein levels decreased significantly at 48 h (0.357 
± 0.155) of reperfusion compared to sham (1.36 ± 
0.274) (n=4, p<0.05; Figure 2A). As shown in Figure 
2A, the decrease in protein levels compared to sham 
were 52%, 48% and 74% at 4 h, 24 h and 48 h, 
respectively. Expression of Pgp returned to near 
initial levels after 1 week (1.32 ± 0.194), where the 
percentage value was 3% lower than sham. The 
corresponding protein-bands for Pgp and β-actin are 
shown in Figure 2B.  
 
 
Table 2. DNA damaged cells as measure by ApopTag in the liver acinus. There was no change in the periportal or 
centrilobular regions, however, the number of DNA damaged cells were significantly increased at 24 h of reperfusion 
(values ± SEM, *p<0.05 vs sham, #p<0.05 vs 1 week, n=4). 
 Periportal Centrilobular Midzonal 
Sham 18.0±2.45  6.00±1.47 14.0±1.08# 
4 hrs 17.8±4.88  43.2±12.8*  112±18.2*  
24 hrs 31.8±9.28  19.3±5.54*  56.8±5.74* 
48 hrs 24.5±10.8  13.5±6.09  72.8±47.6  
1 week 17.3±12.4  3.75±1.89  6.25±2.39  
  
Figure 2. Protein expression of P-glycoprotein. Protein expression (a) of the transporter (Pgp) involved in the excretion of 
Rh123 within the rat liver of sham and I/R injury groups (4, 24, 48 h and 1 week). (b) Western blots of Pgp and β-actin 
expression from four independent rats in sham and I/R injury groups (4, 24, 48 h and 1 week of reperfusion). Values are 
presented as the mean ± SEM (n=4), * p<0.05 significantly different from sham.  
 
Rh123 uptake and excretion in I/R damaged liver 
The individual bile flow rates for the first 60 min 
post-injection in all reperfusion groups are shown in 
Figure 3A-D. The bile flow rates were statistically 
decreased in the 4 h reperfusion group (Figure 3A) 
compared to sham (p<0.05). Area under the curve 
(AUC) was calculated for each individual rat and the 
average value, representing the total amount of bile 
J Pharm Pharm Sci (www.cspsCanada.org) 17(1) 121 - 135, 2014 
 
 
 
127 
excreted after 60 min, is shown in Figure 3E. Biliary 
excretion rates and cumulative excretion amount of 
Rh123 recovered in bile are shown in Figure 4. The 
biliary excretion rate of Rh123 was statistically 
reduced in the 4 h reperfusion group, when compared 
to the sham group (Figure 4A). The area under the 
biliary excretion rate curve (AUC), representing the 
total amount of Rh 123 excreted after 60 min, 
decreased significantly at 4 h of reperfusion (p<0.05; 
Figure 4E).  
 
 
 
 Figure 3. Bile flow rate of Rhodamine 123. Bile flow rate of Rh123 after a) 4 h, b) 24 h, c) 48 h, and d) 1 week of reperfusion.  
e) The total amount of bile excreted after the first 60 min post injection ± SEM, (n=4). Values are presented as the mean ± 
SEM (n=4), * p<0.05 significantly different from sham.  
J Pharm Pharm Sci (www.cspsCanada.org) 17(1) 121 - 135, 2014 
 
 
 
128 
 
 
 Figure 4. Biliary excretion rate of Rhodamine 123. Biliary excretion rate of Rh123 after a) 4 h, b) 24 h, c) 48 h and d) 1 week 
of reperfusion. e) Total amount of Rh123 excreted in the bile after 60 min. Values are presented as the mean ± SEM (n=4), * 
p<0.05 significantly different from sham.  
 
 
MPM images of sham and I/R damaged liver 
were continuously recorded in vivo after bolus 
injection of Rh123 to monitor differences in uptake 
and clearance of the dye. As shown in a 
representative imaged liver (Figure 5), Rh123 
fluorescence intensity was higher for all I/R groups 
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at all time points and Rh123 fluorescence took longer 
to diminish compared to sham. Fluorescence 
intensity for the 1 week I/R group diminished faster 
than that for the other I/R groups, however, it was 
still greater than the sham group. The intensity of 
Rh123 in hepatocytes was converted into 
concentrations using a standard curve prepared in 
homogenized liver. Accumulation of Rh123 in 
hepatocytes was determined by calculating AUC of 
concentrations versus time profiles (Figure 6). The 
results show significantly increased accumulation of 
Rh123 in the hepatocytes at 24 h of reperfusion in the 
I/R injury group compared to sham. The 48 hr time 
point was also higher but did not reach statistical 
significance (p=0.07). The AUC at 1 week showed a 
decline in values, consistent with an increase in Pgp 
levels (Figure 2).  
 
DISCUSSION 
 
The present study aims to investigate the function of 
Pgp in long-term I/R injury using in vivo MPM in 
combination with traditional in vitro techniques such 
as HPLC to study biliary excretion and Western blot 
that was used to evaluate transporter level. In 
addition, histopathological analyses were performed 
to evaluate inflammatory cell infiltration and 
apoptosis.  
 
  
Figure 5. Multiphoton microscopy showing Rhodamine 123 distribution in the liver. Representative MPM images of Rh123 
distribution in sham and I/R injury at 4, 24, 48 h and 1 week of reperfusion. Fluorescence intensity images were recorded in 
vivo at 900 nm excitation wavelength for sham and I/R injury groups at various time points using high (X40) magnifications. 
Scale bar indicate a length 40 µm. 
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 Figure 6. Concentration of Rhodamine 123 in the hepatocytes. Change in Rh123 concentration over time within hepatocytes, 
measured by multiphoton microscopy in hepatic I/R injury at a) 4, b) 24, c) 48 h and d) 1 week compared to sham. A standard 
curve of Rh123 fluorescence intensity to concentration was established to measure unknown concentrations by multiphoton 
microscopy. Rh123 accumulation (area under the curve, AUC) was calculated from Rh123 fluorescence intensity changes 
within the hepatocytes. Values are presented as the mean ± SEM (n=3-4). 
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It is well known that I/R injury is divided into 
two phases. The early phase (up to 2 h) is 
characterised by activation of Kupffer cells and free 
radical formation, with the late phase (4-24 h) 
reflecting accumulation of neutrophils and more free 
radical formation (31). In this study we report a 
significant increase in monocytes/macrophages in 
liver of rats with I/R injury at 24 and 48 h 
reperfusion, which returned to baseline values after 
1 week. The number of monocytes/macrophages 
early in I/R injury has previously only been studied 
following 4 h of reperfusion (9) with an increase in 
neutrophils reported at 6-24 h of reperfusion (32). 
The increased number of macrophages/monocytes 
could be a response to inflammatory signals, e.g. 
interferon-γ and tumor necrosis factor (33, 34). In 
addition, macrophages could also proliferate locally, 
called alternatively activated macrophages induced 
by interleukin 4 (IL-4) (35). Macrophage 
proliferation in response to IL-4 has been shown in 
Kupffer cells (35, 36). 
In addition to the inflammatory signal response, 
liver damage also can be assessed by the number of 
apoptotic cells. In the present study there was a 
significant increase in apoptotic cells in the 
centrilobular and midzonal regions at 4 and 24 h 
(Figure 1, Table 2), which confirmed a heterogenous 
spread of liver damage as previously reported (9). 
Positive ApopTag staining of the liver seen in Figure 
1 may be indicative of cells undergoing repair or 
apoptosis (37), as the DNA is stained in the damaged 
nuclei of affected cells (38). In addition, significantly 
increased levels of ALT were seen at 4 and 24 h, 
indicating extensive liver damage caused by I/R 
injury. This coincides with previous published data 
(39, 40), and suggests that the ApopTag staining was 
indicative of apoptosis rather than repair. A 
comprehensive study of cellular damage in long-
term hepatic I/R injury prior to the present study has 
to our knowledge not been reported. Zonal spread of 
damage in different liver diseases, however, has been 
shown. For example, in alcohol induced liver injury, 
hypoxia and free radical production were shown to 
affect the centrilobular region (41), whereas in 
cancer and cirrhosis the midzonal region was more 
susceptible to oxidative stress (42). In addition, the 
centrilobular and midzonal regions were the most 
affected following acetaminophen administration 
(43). 
It is reasonable to say that the cellular changes in 
I/R injury must impact transporters located in cell 
membranes, which play a critical role in drug 
disposition (44). Thus, it is important to study the 
function of transporters in liver disease in order to 
predict the hepatic and biliary/intestinal exposure of 
drugs and metabolites (45). A limited number of 
reports describe hepatic transporter function in I/R 
injury (10-12, 19), with a main focus on protein and 
mRNA expression of the transporters. The function 
of the transporters, with respect to uptake and 
excretion of drugs in intact anesthetized animals, 
however, not been investigated. Results show a 
substantial reduction in Pgp expression at 4, 24 and 
48 h reperfusion, which reached statistical 
significance at 48 h (Figure 2A).  I/R injury is known 
to be associated with a reduction in other drug 
transporters (11, 12, 19). For example, Ntcp, Mrp2 
and Bsep were markedly reduced in studies using 
cultured hepatocytes (11) and a similar reduction was 
seen for Mrp2 in liver homogenates after 24 and 48 
h of reperfusion (19). Also, our group reported 
decreased protein expression of Mrp3 in I/R injury 
(46). In addition, protein expression of Pgp was 
measured in intestinal I/R injury, where it was 
significantly decreased after 1 and 3 h of reperfusion 
compared to control (17, 47). mRNA expression of 
mdr1a and mdr1b was not significantly decreased 
(data not shown). 
The bile flow rate was significantly decreased at 
4 h of repefusion (p<0.05), with statistical 
improvement at 24 h to 1 week. This coincided with 
another study of hepatic I/R injury, where the bile 
flow rate was 30 % lower in the I/R group compared 
to sham (48). In addition, another study of I/R injury  
reported significantly decreased bile flow at 24 h, 
which returned to normal values at 72 h (20). It is 
possible that the decreased bile flow is a result of 
impaired microcirculation in the liver. I/R injury has 
previously been described to decreased sinusoidal 
density, hence impair hepatic microcirculation (49, 
50). As a consequence, biliary excretion rate of 
Rh123 was significantly decreased at 4 h of 
reperfusion (p<0.05). A reduced biliary excretion 
rate as well as decreased recovery of Rh123 was 
previously reported in I/R injury at 24 h of 
reperfusion (20, 48). The reduced biliary excretion 
rate found in our study may also be a consequence of 
posttranscriptional regulation or factors such as Pgp 
in vivo half-life (51, 52). A recent study showed that 
the excretion of Rh123 was substantially reduced 
(90%) in the presence of the Pgp inhibitor 
cyclosporine A (53). Moreover, our group showed 
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significantly increased fluorescence of Rh123 in 
hepatocytes after cyclosporine A treatment (30).  
Our work showed that I/R injury decreases the 
excretion of Rh123 and reduces the protein 
expression of Pgp. Thus, our next approach was in 
determining whether we were able to visualize the 
changes in vivo. Results showed significantly 
increased accumulation of Rh123 in the hepatocytes 
in I/R injury at 24 h of reperfusion. These results are 
in agreement with a recent study conducted by our 
group showing that Pgp inhibition by cyclosporine A 
increased the hepatocyte fluorescence of Rh123 (30).  
The decline in hepatocyte fluorescence was slower 
for the cyclosporine A pre-treated group than in 
control (30). In another recent study by our group, 
we showed that the transport of fluorescein was 
impaired in hepatic I/R injury (46). The present 
results show that MPM can be used to study drug 
distribution and transporter function in liver injury 
models in vivo. It is beneficial to conventional drug 
distribution studies, such as the isolated perfused 
liver, in that it directly observes how concentrations 
of a drug change over time and in space in intact 
animals and is arguably a better model of 
understanding drug distribution (30). In addition, 
there is no artificial perturbation of hepatic blood 
flow. Drug is delivered to the liver via both the intact 
hepatic artery and portal vein. Moreover, MPM 
allows for simultaneous examination of cellular 
morphology in intact animals (21).  
 
CONCLUSIONS 
 
The present study confirmed that I/R injury caused 
heterogeneous spread of the damage across the liver 
acinus. Short term I/R injury (4 h) resulted in 
impaired biliary excretion of Rh123 as a result of 
reduced bile flow and decreased protein expression 
of Pgp. Multiphoton microscopy showed increased 
fluorescence intensity in hepatocytes in early I/R 
injury, which recovered after 1 week. The findings 
here stipulate that drugs excreted by P-glycoprotein 
could be affected after liver surgery and that care 
should be taken in drug dosing in these situations.  
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